ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Market Cap	59.97B
Revenue (ttm)	67.02B
Net Income (ttm)	4.77B
Shares Out	28.40M
EPS (ttm)	168.05
PE Ratio	12.57
Forward PE	11.09
Dividend	55.00 (2.52%)
Ex-Dividend Date	Mar 30, 2026

Volume	161,800
Average Volume	73,505
Open	2,100.00
Previous Close	2,112.00
Day's Range	2,080.00 - 2,157.00
52-Week Range	1,825.00 - 2,942.00
Beta	0.16
RSI	58.42
Earnings Date	Feb 2, 2026

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1920
• Employees: 1,632
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4886

Financial Performance

In 2024, TYO:4886's revenue was 64.14 billion, an increase of 2.06% compared to the previous year's 62.84 billion. Earnings were 5.10 billion, a decrease of -32.39%.